Shanghai Allist Pharmaceuticals Co., Ltd. (SHA:688578)

China · Delayed Price · Currency is CNY

92.71

-0.02 (-0.02%)

Feb 27, 2026, 3:00 PM CST

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
Research and Development of Drugs	3.56B	2.02B	791.00M	530.09M	560.89K
Research and Development of Drugs Growth	76.29%	155.14%	49.22%	94409.97%	-10.93%
Total	3.56B	2.02B	791.00M	530.09M	560.89K
Total Growth	76.29%	155.14%	49.22%	94409.97%	-10.93%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
China	3.56B	-	-	-	560.89K
China Growth	-	-	-	-	-10.93%
Total	3.56B	-	-	-	560.89K
Total Growth	-	-	-	-	-10.93%

Source: S&P Global Market Intelligence.